Quarterly report pursuant to Section 13 or 15(d)

Insider Trading Arrangements

v3.24.1.u1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement

Director and Officer Trading Arrangements

 

On March 15, 2024, Yuval Cohen, Ph.D., the Company's Chief Executive Officer and a member of the board of directors adopted a Rule 10b5-1 plan providing for the sale of up to 117,066 shares of the Company’s common stock. Pursuant to this plan, Dr. Cohen may sell shares of common stock beginning on June 13, 2024, subject to the terms of the agreement, and the plan terminates on March 15, 2025. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c).

Also on March 15, 2024, Sean Moran, the Company’s Chief Financial Officer, adopted a Rule 10b5-1 plan providing for the sale of up to 42,606 shares of common stock. Pursuant to this plan, Mr. Moran may sell shares beginning on June 13, 2024, subject to the terms of the agreement, and the plan terminates on March 15, 2025. The trading arrangement is intended to satisfy the affirmative defense of Rule 10b5-1(c).

 

No other directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the first quarter of 2024.

Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Yuval Cohen [Member]  
Trading Arrangements, by Individual  
Name Yuval Cohen
Title Chief Executive Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 15, 2024
Termination Date March 15, 2025
Aggregate Available 117,066
Sean Moran [Member]  
Trading Arrangements, by Individual  
Name Sean Moran
Title Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date March 15, 2024
Termination Date March 15, 2025
Aggregate Available 42,606